13 November 2014

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that David Davies has decided to leave the Company to pursue new opportunities. Mr Davies' departure from the Company will take place during the first half of next year after the transition of his responsibilities to Futura's recently strengthened product development team. The effective date of his ceasing to be a Director of the Company will be confirmed in due course.

James Barder, Futura's Chief Executive, said: "David has been with Futura for a total of 13 years, during which time the Company has evolved considerably. I would like to thank David for his contribution to Futura and wish him well for the future."


For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670

Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong / Thomas Smale
Tel: +44 (0) 20 7496 3000

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Sophie Cowles /
Stephanie Watson
Tel: +44 (0) 20 7466 5000


Notes to Editors:

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups. Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.